Kelsey Goodwin

Q: What is Kelsey Goodwin's success rate?

Kelsey Goodwin currently has a success rate of 92.92569130427287.

Q: What is the average return of Kelsey Goodwin's calls?

Their stock ratings have generated an average return of 49.6864862977653.

Piper Sandler | Healthcare

Kelsey Goodwin is an analyst from Piper Sandler specializing in the Healthcare sector. Ranked #262 out of 4662 analysts, they have issued 28 stock ratings with a success rate of 92.93% and an average return of 49.69%.

Kelsey Goodwin has a well-established track record, with 28 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.93% and an average return of 49.69%, underscoring their expertise and ability to identify winning opportunities for investors.

#262

Out of 4662

Total Ratings

+92.93%

Success Rate

+49.69%

Average Return

Recent Ratings Analysis

LONA

Buy

May 27, 2026

Target

$20.00

Current

$9.67

Performance

—

Kelsey Goodwin rated LONA as Overweight on May 27, 2026, setting a price target of 20. Shares have remained stable near 9.67, leaving the 20 target still in play.

TNGX

Hold

May 15, 2026

Target

$24.00

Current

$20.04

Performance

-2.53%

On May 15, 2026, TNGX was given a Neutral rating by Kelsey Goodwin, with a target price of 24. Market indecision, reflected in sideways trading near 20.04, supported the cautious call.

JANX

Buy

May 08, 2026

Target

$26.00

Current

$14.40

Performance

1.55%

JANX received a Overweight rating from Kelsey Goodwin on May 08, 2026, aiming for 26. Price action was muted, as shares hovered around 14.4 despite the bullish outlook.

RVMD

Buy

May 07, 2026

Target

$172.00

Current

$154.89

Performance

8.69%

On May 07, 2026, Kelsey Goodwin published a Overweight outlook on RVMD, with a target of 172. Shares gained 8.69%, underscoring the accuracy of the bullish outlook toward 172.

SMMT

Hold

May 01, 2026

Target

$16.00

Current

$17.00

Performance

—

Kelsey Goodwin on May 01, 2026 assigned SMMT a Neutral rating, with a price target of 16. The Hold stance reflected consolidation, as shares held near 17.

RLMD

Buy

Mar 24, 2026

Target

$12.00

Current

$7.17

Performance

17.54%

On Mar 24, 2026, Kelsey Goodwin reaffirmed RLMD with a Overweight rating, targeting 12. The recommendation was supported by strong follow-through as the stock rose from 7.17 to 7.17.

ERAS

Buy

Mar 13, 2026

Target

$18.00

Current

$11.50

Performance

-15.57%

ERAS was rated Overweight by Kelsey Goodwin on Mar 13, 2026, with a price objective of 18. This case shows how bullish projections can fail, with the stock now below 11.5.

ACLX

Hold

Feb 26, 2026

Target

$120.00

Current

$115.07

Performance

1.04%

On Feb 26, 2026, Kelsey Goodwin initiated coverage on ACLX with a Neutral rating and target of 120. The stock’s lack of movement around 115.07 aligned with a cautious approach.

CGON

Buy

Jan 16, 2026

Target

$70.00

Current

$61.89

Performance

13.08%

Kelsey Goodwin issued a Overweight recommendation for CGON on Jan 16, 2026, price target set at 70. Investors following the Buy call captured upside momentum, with shares now at 61.89.

BDTX

Buy

Jan 16, 2026

Target

$8.00

Current

$2.33

Performance

-8.98%

On Jan 16, 2026, BDTX was evaluated by Kelsey Goodwin, who gave a Overweight rating and target of 8. Investors saw limited payoff as shares fell short of the 8 target.

ORIC

Buy

Jan 07, 2026

Target

$22.00

Current

$8.54

Performance

-1.61%

Kelsey Goodwin rated ORIC as Overweight on Jan 07, 2026, setting a price target of 22. Shares have remained stable near 8.54, leaving the 22 target still in play.

TARA

Buy

Jan 07, 2026

Target

$24.00

Current

$4.80

Performance

-15.64%

On Jan 07, 2026, TARA was given a Overweight rating by Kelsey Goodwin, with a target price of 24. Despite the Buy call, shares fell from 4.8 to 4.8, challenging the optimistic stance.

DAWN

Buy

Nov 05, 2025

Target

$26.00

Current

$21.53

Performance

135.56%

DAWN received a Overweight rating from Kelsey Goodwin on Nov 05, 2025, aiming for 26. Momentum has favored the Buy call, with shares climbing from 21.53 to 21.53, rewarding those who trusted the recommendation.

NUVL

Buy

Oct 27, 2025

Target

$128.00

Current

$104.95

Performance

7.41%

On Oct 27, 2025, Kelsey Goodwin published a Overweight outlook on NUVL, with a target of 128. Shares gained 7.41%, underscoring the accuracy of the bullish outlook toward 128.

BCAX

Buy

Aug 19, 2025

Target

$36.00

Current

$21.98

Performance

90.96%

Kelsey Goodwin on Aug 19, 2025 assigned BCAX a Overweight rating, with a price target of 36. The Buy call aligned well with market performance, producing a gain of 90.96%.

URGN

Buy

Aug 19, 2025

Target

$36.00

Current

$29.46

Performance

55.71%

On Aug 19, 2025, Kelsey Goodwin reaffirmed URGN with a Overweight rating, targeting 36. The recommendation was supported by strong follow-through as the stock rose from 29.46 to 29.46.

IPSC

Buy

Mar 28, 2025

Target

—

Current

$2.17

Performance

323.08%

IPSC was rated Buy by Kelsey Goodwin on Mar 28, 2025, with a price objective of null. A bullish response from the market helped close the gap of -2.17 to the target.

MGNX

Hold

Jul 31, 2024

Target

—

Current

$4.47

Performance

18.88%

On Jul 31, 2024, Kelsey Goodwin initiated coverage on MGNX with a Neutral rating and target of null. The Hold stance underestimated the stock’s strength as it gained 18.88%.

Frequency Asked Questions

Who is Kelsey Goodwin?

Kelsey Goodwin is an analyst from Piper Sandler specializing in the Healthcare sector.

What is Kelsey Goodwin's success rate?

Kelsey Goodwin currently has a success rate of +92.93%.

How many ratings has Kelsey Goodwin issued?

Kelsey Goodwin has issued 28 stock ratings so far.

What is the average return of Kelsey Goodwin's calls?

Their stock ratings have generated an average return of +49.69%.

What is Kelsey Goodwin's ranking?

Kelsey Goodwin is ranked #262 out of 4662 analysts.

What types of ratings does Kelsey Goodwin give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Kelsey Goodwin?

You can follow Kelsey Goodwin by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Kelsey Goodwin?

Their latest rating was a Buy on LONA issued on 2026-05-27.